Skip to main content

About us

Strengthening cooperation with industry

SLS Techno Trans AG is funded by our shareholders to make the research opportunities at the Swiss Light Source more visible to industry. It coordinates interactions between industry and PSI scientists specialised in the relevant fields and experimental techniques.

The aims of the company are to support the transfer of technology, to look after the development of specific beam lines to serve the requirements of industry, and to take care of industry research activities.

SLS Techno Trans AG was founded in 1997 when the Swiss Light Source was still in the design phase to strengthen cooperation with industry and make a strong commitment to guarantee open access to industry and academic researchers. From the very start of user operations at the Swiss Light Source, there has been a protein crystallography beamline dedicated to collaborations with the Swiss pharmaceutical industry.

We are proactive in identifying how new experimental techniques at the Swiss Light Source can be used by industry.


Our Shareholders

  • Paul Scherrer Institute
  • Fachhochschule Nordwestschweiz
  • Oerlikon Metco
  • Novartis AG
  • MPS Micro Precision Systems AG
  • BRUGG GROUP AG

European Collaboration Partners

To foster SME innovation and competitiveness, the European project LEAPS-INNOV aims to build capacity in industry, particularly for small and medium enterprises (SMEs) to use light sources for their research and innovation needs, and to lower the barriers for accessing European light source facilities.

The European Light source for Industrial Innovation (ELSII) collaboration was launched in 2017. The ELSII collaboration helps to strengthen connections and build a network between colleagues working with industry users at other European synchrotron radiation and free electron laser facilities.

The Tailor-made for SMEs Transnational Access (TamaTA) scheme is providing SMEs access to light source infrastructures through a central entry point. Through a 'voucher scheme', successful SMEs obtain a pre-defined amount of beam time and data analysis hours.

The Paul Scherrer Institute thanks the European Commission for the funding received to support industry related activities under LEAPS-INNOV (Horizon 20202 / Grant Agreement No 101004728).


How we work

Our services are provided either by our team of industry partner scientists at the Swiss Light Source beamlines or through our spin-off companies: EXPOSE for protein crystallography, or Excelsus Structural Solutions for materials science.
ANAXAM

ANAXAM provides industry access to advanced analytical methods using neutrons and synchrotron radiation (x-rays) particularly at the Paul Scherrer Institute, originally developed for basic research. ANAXAM collaborates with industry based on the "public-private partnership".
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. / https://www.anaxam.ch/en

EXPOSE GmbH

Expose provides data collection and screening of protein and small molecule crystals at the Swiss Light Source for companies in the pharmaceutical and biotechnology sectors. Services include: data collection, screening, data processing and analysis, protein structure solution and ligand refinement.
Contact: Dr. Joachim Diez, This email address is being protected from spambots. You need JavaScript enabled to view it.

Excelsus Structural Solutions

Excelsus offers easy and affordable access to unique synchrotron-based characterisation tools developed at the Paul Scherrer Institute, to enhance the selection, development and manufacturing of high-quality (bio)pharmaceutical products.
Contact: Dr. Fabia Gozzo, This email address is being protected from spambots. You need JavaScript enabled to view it.